Cruciferous Vegetables, Mushrooms, and Gastrointestinal Cancer Risks in a Multicenter, Hospital-Based Case-Control Study in Japan

Nutrition and Cancer

Volumn 46, Issue 2, 2003, Pages 138-147

  Hara, Megumi ^a,b   Hanaoka, Tomoyuki ^a   Kobayashi, Minatsu ^a   Otani, Tetsuya ^a   Adachi, Helena Yukari ^a   Montani, Ai ^a   Natsukawa, Syusuke ^c   Shaura, Kozo ^d   Koizumi, Yoichi ^e   Kasuga, Yoshio ^f   Matsuzawa, Tsunetomo ^g   Ikekawa, Tetsuro ^g   Sasaki, Satoshi ^a,h   Tsugane, Shoichiro ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b SAGA UNIVERSITY   (Japan)

^c Saku General Hospital   (Japan)

^d Hokushin General Hospital   (Japan)

^e Shinonoi General Hospital   (Japan)

^f Nagano Matsushiro General Hospital   (Japan)

^g Agricultural Technology Institute   (Japan)

^h NATIONAL INSTITUTE OF HEALTH AND NUTRITION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BROCCOLI; CANCER RISK; CASE CONTROL STUDY; COLORECTAL CANCER; CONTROLLED STUDY; DIETARY INTAKE; DIGESTIVE SYSTEM CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MUSHROOM; RISK FACTOR; STOMACH CANCER; VEGETABLE;

BASIDIOMYCOTA; BRASSICA OLERACEA VAR. BOTRYTIS; BRASSICA OLERACEA VAR. CAPITATA; BRASSICA RAPA SUBSP. PEKINENSIS;

EID: 10744222281     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/S15327914NC4602_06     Document Type: Article

References (49)

1. Botterweck AA, van den Brandt PA, and Goldbohm RA: A prospective cohort study on vegetable and fruit consumption and stomach cancer risk in the Netherlands. Am J Epidemiol 148, 842-853, 1998.
2. Botterweck AA, van den Brandt PA, and Goldbohm RA: Vitamins, carotenoids, dietary fiber, and the risk of gastric carcinoma: results from a prospective study after 6.3 years of follow-up. Cancer 88, 737-748, 2000.
3. McCullough ML, Robertson AS, Jacobs EJ, Chao A, Calle EE, et al.: A prospective study of diet and stomach cancer mortality in United States men and women. Cancer Epidemiol Biomarkers Prev 10, 1201-1205, 2001.
4. Michels KB, Edward G, Joshipura KJ, Rosner BA, Stampfer MJ, et al.: Prospective study of fruit and vegetable consumption and incidence of colon and rectal cancers. J Natl Cancer Inst 92, 1740-1752, 2000.
5. Kobayashi M, Tsubono Y, Sasazuki S, Sasaki S, and Tsugane S: Vegetables, fruit and risk of gastric cancer in Japan: a 10-year follow-up of the JPHC study Cohort I. Int J Cancer 102, 39-44, 2002.
6. Blot WJ, Li JY, Taylor PR, Guo W, Dawsey S, et al.: Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 85, 1483-1492, 1993.
7. The Alpha-tocopherol BCCPSG: the effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 330, 1029-1035, 1994.
8. Correa P, Fontham ET, Bravo JC, Bravo LE, Ruiz B, et al.: Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy. J Natl Cancer Inst 92, 1881-1888, 2000.
9. Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, et al.: Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 334, 1145-1149, 1996.
10. Malila N, Virtamo J, Virtanen M, Albanes D, Tangrea JA, et al.: The effect of alpha-tocopherol and beta-carotene supplementation on colorectal adenomas in middle-aged male smokers. Cancer Epidemiol Biomarkers Prev 8, 489-493, 1999.
11. Alberts DS, Martinez ME, Roe DJ, Guillen-Rodriguez JM, Marshall JR, et al.: Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians' Network. N Engl J Med 342, 1156-1162, 2000.
12. Giovannucci E, Stampfer MJ, Colditz GA, Hunter DJ, Fuchs C, et al.: Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study. Ann Intern Med 129, 517-524, 1998.
13. Evans RC, Fear S, Ashby D, Hackett A, Williams E, et al.: Diet and colorectal cancer: an investigation of the lectin/galactose hypothesis. Gastroenterology 122, 1784-1792, 2002.
14. Chyou PH, Nomura AM, Hankin JH, and Stemmermann GN: A case-cohort study of diet and stomach cancer. Cancer Res 50, 7501-7504, 1990.
15. Steinmetz KA, Kushi LH, Bostick RM, Folsom AR, and Potter JD: Vegetables, fruit, and colon cancer in the Iowa Women's Health Study. Am J Epidemiol 139, 1-15, 1994.
16. Dorant E, van den Brandt PA, and Goldbohm RA: A prospective cohort study on the relationship between onion and leek consumption, garlic supplement use and the risk of colorectal carcinoma in the Netherlands. Carcinogenesis 17, 477-484, 1996.
17. Dorant E, van den Brandt PA, Goldbohm RA, and Sturmans F: Consumption of onions and a reduced risk of stomach carcinoma. Gastroenterology 110, 12-20, 1996.
18. Harrison LE, Zhang ZF, Karpeh MS, Sun M, and Kurtz RC: The role of dietary factors in the intestinal and diffuse histologic subtypes of gastric adenocarcinoma: a case-control study in the U.S. Cancer 80, 1021-1028, 1997.
19. Ekstrom AM, Serafini M, Nyren O, Hansson LE, Ye W, et al.: Dietary antioxidant intake and the risk of cardia cancer and noncardia cancer of the intestinal and diffuse types: a population-based case-control study in Sweden. Int J Cancer 87, 133-140, 2000.
20. Fleischauer AT and Arab L: Garlic and cancer: a critical review of the epidemiologic literature. J Nutr 131, 1032S-1040S, 2001.
21. Kim HJ, Chang WK, Kim MK, Lee SS, and Choi BY: Dietary factors and gastric cancer in Korea: a case-control study. Int J Cancer 97, 531-535, 2002.
22. Voorrips LE, Goldbohm RA, van Poppel G, Sturmans F, Hermus RJ, et al.: Vegetable and fruit consumption and risks of colon and rectal cancer in a prospective cohort study: the Netherlands Cohort Study on Diet and Cancer. Am J Epidemiol 152, 1081-1092, 2000.
23. Sasaki S, Kobayashi M, and Tsugane S: Validity of a self-administered food frequency questionnaire used in the 5-year follow-up survey of the JPHC Study Cohort I: comparison with dietary records for food groups. J Epidemiol 13 Suppl, S57-S63, 2003.
24. The General Rules for the Gastric Cancer Study. Japanese Research Society for Gastric Cancer 12th ed, Tokyo, 1993.
25. The General Rules for Clinical and Pathological Studies on Cancer of the Colon, Rectum and Anus. Japanese Society for Cancer of the Colon and Rectum 6th ed, Tokyo, 1998.
26. Hanai A and Fujimoto I. Cancer incidence in Japan in 1975 and changes of epidemiological features for cancer in Osaka. Natl Cancer Inst Monogr 62, 3-7, 1982.
27. Laurén P: The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbial Scand 64, 31-49, 1965.
28. SAS Institute, Inc.: SAS/STAT Users Guide Version 8. Cary, NC: SAS Institute Inc., 1999.
29. The Ministry of Health and Welfare: Detail Report of Vital Statistics of Japan, 1993-1997 (Jinkodotai hokenzyo Shikucyosonbetsu Tokei). Health and Welfare Statistics Association, Tokyo, 1999.
30. McDanell R, McLean AE, Hanley AB, Heaney RK, and Fenwick GR: Chemical and biological properties of indole glucosinolates (glucobrassicins): a review. Food Chem Toxicol 26, 59-70, 1988.
31. Talalay P and Fahey JW: Phytochemicals from cruciferous plants protect against cancer by modulating carcinogen metabolism. J Nutr 131, 3027S-3033S, 2001.
32. Wattenberg LW: Chemoprevention of cancer. Cancer Res 45, 1-8, 1985.
33. Verhoeven DT, Verhagen H, Goldbohm RA, van den Brandt PA, and van Poppel G: A review of mechanisms underlying anticarcinogenicity by brassica vegetables. Chem Biol Interact 103, 79-129, 1997.
34. Bonnesen C, Eggleston IM, and Hayes JD: Dietary indoles and isothiocyanates that are generated from cruciferous vegetables can both stimulate apoptosis and confer protection against DNA damage in human colon cell lines. Cancer Res 61, 6120-6130, 2001.
35. Kato I, Tominaga S, Ito Y, Kobayashi S, Yoshii Y, et al.: A comparative case-control analysis of stomach cancer and atrophic gastritis. Cancer Res 50, 6559-6564, 1990.
36. Boeing H, Jedrychowski W, Wahrendorf J, Popiela T, Tobiasz-Adamczyk B, et al.: Dietary risk factors in intestinal and diffuse types of stomach cancer: a multicenter case-control study in Poland. Cancer Causes Control 2, 227-233, 1991.
37. Buiatti E, Palli D, Bianchi S, Decarli A, Amadori D, et al.: A case-control study of gastric cancer and diet in Italy. III. Risk patterns by histologic type. Int J Cancer 48, 369-374, 1991.
38. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 49, 347-353, 2001.
39. Tsugane S, Kabuto M, Imai H, Gey F, Tei Y, et al.: Helicobacterpylori, dietary factors, and atrophic gastritis in five Japanese populations with different gastric cancer mortality. Cancer Causes Control 4, 297-305, 1993.
40. Asaka M, Kimura T, Kudo M, Takeda H, Mitani S, et al.: Relationship of Helicobacterpylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology 102, 760-766, 1992.
41. Yamagata H, Kiyohara Y, Aoyagi K, Kato I, Iwamoto H, et al.: Impact of Helicobacter pylori infection on gastric cancer incidence in a general Japanese population: the Hisayama study. Arch Intern Med 160, 1962-1968, 2000.
42. van Poppel G, Verhoeven DT, Verhagen H, and Goldbohm RA: Brassica vegetables and cancer prevention. Epidemiology and mechanisms. Adv Exp Med Biol 472, 159-168, 1999.
43. Ikekawa T, Ikeda Y, Yoshioka Y, Nakanishi K, Yokoyama E, et al.: Studies on antitumor polysaccharides of Flammulina velutipes (Curt. ex Fr.) Sing. II. The structure of EA3 and further purification of EA5. J Pharmacobiodyn 5, 576-581, 1982.
44. Ikekawa T, Maruyama H, Miyano T, Okura A, Sawasaki Y, et al.: Proflamin, a new antitumor agent: preparation, physicochemical properties and antitumor activity. Jpn J Cancer Res 76, 142-148, 1985.
45. Ng TB: A review of research on the protein-bound polysaccharide (polysaccharopeptide, PSP) from the mushroom Coriolus versicolor (Basidiomycetes: Polyporaceae). Gen Pharmacol 30, 1-4, 1998.
46. Toth B, Nagel D, and Ross A: Gastric tumorigenesis by a single dose of 4-(hydroxymethyl)benzenediazonium ion of Agaricus bisporus. Br J Cancer 46, 417-422, 1982.
47. Toth B and Erickson J: Cancer induction in mice by feeding of the uncooked cultivated mushroom of commerce Agaricus bisporus. Cancer Res 46, 4007-4011, 1986.
48. Wang HX, Liu WK, Ng TB, Ooi VE, and Chang ST: The immunomodulatory and antitumor activities of lectins from the mushroom Tricholorna mongolicum. Immunopharmacology 31, 205-211, 1996.
49. Borchers AT, Stem JS, Hackman RM, Keen CL, and Gershwin ME: Mushrooms, tumors, and immunity. Proc Soc Exp Biol Med 221, 281-293, 1999.